During embryonic life, hematopoiesis occurs first in the yolk sac, followed by the aortogonado-mesonephric region, the fetal liver and the bone marrow. The possibility of hematopoiesis in other embryonic sites has been suspected for a long time. Using different methodologies (transgenic mice, electron microscopy, laser capture microdissection, organ culture and cross-transplants experiments) we show that multiple regions within the embryo are capable of forming blood before and during organogenesis. This widespread phenomenon occurs by hemo-vasculogenesis, the formation of blood vessels accompanied by the simultaneous generation of red blood cells. Erythroblasts develop within aggregates of endothelial cell precursors. When the lumen forms the erythroblasts "bud" from endothelial cells into the forming vessel. The extensive hematopoietic capacity found in the embryo helps explain why, under pathological circumstances such as severe anemia, extramedullary hematopoiesis can occur in any adult tissue. Understanding the intrinsic ability of tissues to manufacture their own blood cells and vessels has the potential to advance the fields of organogenesis, regeneration, and tissue engineering.
INTRODUCTION
In the vertebrate embryo, hematopoietic and vascular endothelial cells are the first cells to differentiate in response to induction of the mesoderm (2) . In mice, endothelial cells and hematopoietic cells are first observed (when primitive hematopoiesis begins) in the yolk sac at 7.5 days post coitum (9) . Primitive hematopoiesis is restricted to the formation of nucleated erythrocytes that express embryonic hemoglobin (43) and macrophages (7) .
Definitive hematopoiesis is the process whereby all types of blood cells are formed followed by their differentiation, including the enucleation of erythrocytes. The initial site of definitive hematopoiesis is controversial. It has been proposed that the first site is in the splanchnopleural/aorto-gonado-mesonephric (SP/AGM) area (10; 14; 24) and that early in development endothelial cells from the AGM region may themselves give rise to hematopoietic cells (6; 20; 37) . As embryonic development continues, the site for hematopoiesis changes to the fetal liver and as the animal matures to the bone marrow, where hematopoiesis persists in the adult. The possibility of hematopoiesis occurring in other embryonic sites has not been explored.
During development of the yolk sac hematopoiesis is intimately linked to the development of blood vessels. In fact, the ontogenic relationship between hematopoietic cells and the endothelial cells of the blood islands of the yolk sac has been observed almost one hundred years ago (34) . Similar observation has also been made in the aorta and post umbilical and vitelline arteries where hematopoietic clusters seem to originate from hemogenic endothelium (6; 18; 20; 37) . The existence of a common precursor for endothelial cells and hematopoietic cells, the hemangioblast, has been suspected for a long time (25; 30; 31; 34) . Taken altogether these observations suggest that vasculogenesis and hematopoiesis are part of the same process, in which formation of a blood vessel is accompanied by the simultaneous, in situ production of blood cells within that vessel (hemo-vasculogenesis).
Our experiments show that: i) hematopoiesis is widespread in the embryo: in addition to the aorto-gonado-mesonephric area, fetal liver, and bone marrow, the embryo makes erythroblasts in every tissue examined before and during organogenesis ii) hematopoiesis is tied to and integrated with the differentiation and morphogenesis of blood vessels: formation of a vessel is accompanied by the generation of red cell precursors suggesting that hematopoietic and vascular cells share a common precursor.
MATERIALS AND METHODS

Animals.
Several mouse strains were studied: expressing Lac-Z driven by the Tie2 promoter (marks endothelial cells) (35) or under the control of the -globin LCR-promoter combination (marks erythroid cells) (16) , expressing cre recombinase driven by the Tie2 promoter (22) , ubiquitously expressing Lac-Z (ROSA 26), the ROSA26 Lox P reporter mice (38) , and wild type C57B6.
Embryos at 11.5 days of gestation (E11.5) were the source of fetal kidneys used for in vitro culture and for grafting under the kidney capsule. Time-dated pregnant mice were mated overnight and the females were checked for vaginal plugs the following morning. The day of detection of a vaginal plug was regarded as day 0.5 of gestation. Grafting of embryonic kidneys under the kidney capsule was performed as previously described (36) . All procedures were performed in accordance with the guidelines of the American Physiological Society (1) and were approved by the University of Virginia Animal Care Committee.
Immunohistochemistry and X-gal reaction.
Embryonic tissues from mice were subjected to the X-gal reaction, paraffin embedded, sectioned (5 m) and immunostained as previously described (36) . The antibodies used were anti -smooth muscle actin ( -SMA) (Sigma) and anti-hemoglobin (DAKO).
Electron microscopy studies E9.5 and E11.5 mouse embryos were dissected and fixed with 4% PFA and 2.5% glutaraldehyde at 4 o C overnight, then postfixed in OsO 4 , embedded in epoxy resin by conventional methods, cut into 70 to 80 nm sections, and examined using a JEOL 100 CX transmission electron microscope.
Metanephric kidney culture E11.5 kidneys from -globin/LacZ + embryos (n=24) were cultured for 72 h at 37º C as previously described (29) . The defined serum free medium (DMEM-F12) was supplemented with 10 mM HEPES, 1.1 mg/ml NaHCO 3 , 5 ug/ml Insulin and Transferrin, 2.8 nM Selenite (Sigma), 25 ng/ml PGE1 (Sigma), 32 pg/ml Triiodothyronine (Sigma), 50 U/ml penicillin G and 50 U/ml mycostatin. The medium with additives was changed daily.
Metanephric kidney culture on top of Embryonic Stem (ES) cells.
ES cells from SVEV mice were grown on top of irradiated feeder layers of primary murine embryonic fibroblasts placed on top of cell culture inserts with 3 m pore size (Falcon) on a 6 well dish. 48h later, E12 kidneys (n=17) from ROSA26 mice were dissected as previously described (36) , and placed on top of the ES cell colonies for 5 days. Medium containing DMEM-H's (Gibco) supplemented with 15% FBS (Gibco), 1% Sodium Pyruvate (Gibco), 0.0008% -mercaptoethanol (Sigma), 5 ug/ml Insulin and Transferrin, 2.8 nM Selenite (Sigma), 25 ng/ml PGE1 (Sigma), 32 pg/ml Triiodothyronine (Sigma) and 15mU/ml Erythropoietin (Sigma) was changed daily. Embryonic kidneys were fixed and subjected to the X-Gal reaction as previously described (36) .
Peripheral blood extraction.
Mouse embryos at E12.5 and E14.5 were dissected from the uterus, membranes were opened, and the umbilical cord was cut to let blood flow out from the cord. Blood samples were then collected using a P10 pipette. From anesthetized adult animals, blood was collected from the abdominal aorta using a 1cc syringe and a 23G needle.
Laser Capture Microdissection (LCM). Negative controls included reaction without reverse transcriptase and without RNA. The PCR product was separated on 1% agarose gel stained with ethidium bromide.
RESULTS AND DISCUSSION
Erythropoiesis throughout the embryo.
To study the lineage relationship between endothelial and erythroid cells and to define whether the latter cells and blood vessels develop simultaneously from a common precursor as a widespread phenomenon occurring throughout the embryo, we examined mouse embryos expressing LacZ under the control of the Tie2 promoter (marks endothelial cells) (35) or under the control of the -globin LCR-promoter combination (marks erythroid cells) (16) . In addition,
to define whether endothelial cell precursors give origin to blood cells, we examined embryos derived from the cross of Tie2-Cre (22) with the ROSA26 Lox P reporter mice (38) . In mice Table 1 .
Hematopoiesis by budding.
Clusters of hematopoietic cells have previously been observed within the aorta, the vitelline and the umbilical arteries (13; 20; 27; 32; 44) . Budding cells from endothelial cells in the floor of the aorta have been described (13; 20; 32) and the concept of a hemogenic endothelium has been proposed based on in vivo and in vitro studies that demonstrate that hematopoietic cells can be generated from endothelial cells (6; 18; 20; 26; 37) .
Our results show that budding of hematopoietic cells from endothelial cells is not restricted to a few areas and is observed throughout the mouse embryo (Figure 3 and 6) . B-C describes different stages of the budding process found throughout the embryo and Figure 6 A-C shows, at high magnification, the tight relationship between an endothelial cell and an erythroblast during the budding process; indicating that it is not non-specific sticking of erythroid cells or circulating endothelial cells. Clearly, the presence of "budding" hematopoietic cells is a common occurrence throughout the embryo and is encountered in a variety of tissue types, including kidney, brain, skin, and others (see Figures 1-3 and 6) . The "budding" process seen here in small developing vessels mimics the budding of blood cells from endothelial cells that occurs in the aorta as seen in Figure 6 H and I. Furthermore, electron microscopy studies of developing vessels within the head of mice embryos (E9.5 and E11.5) allowed us to show the intimate relationship between erythroblasts and endothelial cells during vessel formation and to reconstruct the main stages of hemo-vasculogenesis ( Figure 7 ).
Hemo-vasculogenesis start as an aggregate of cells (Figure 7 A.) Eventually, the cells undergo further differentiation into erythroblasts and vascular cells (Figure 7 B) . Then, a cavity(s) is formed followed by formation of a lumen and the separation of erythroblasts from endothelial cells (Figure 7 B-F) . The fact that the process starts as a cell aggregate containing both cell types (erythroblasts and endothelial cells) before lumen formation has occurred suggests that both cell types develop in situ, a process that we described as hemo-vasculogenesis. The kidney as a model for hematopoiesis during organogenesis.
To address the question whether hematopoiesis occurs during organogenesis, we chose the kidney as a model to perform further experiments. We demonstrate herein that the embryonic kidney is capable of producing its own blood cells, particularly cells of the erythroid lineage.
Although it has been suggested that the AGM area is a site for blood formation in the early 
CONCLUSIONS
It has been well recognized that during embryonic life hematopoiesis occurs first in the yolk sac followed by the AGM region, the fetal liver and then the bone marrow. In the present study we used different approaches and techniques and showed that multiple embryonic tissues have the capacity to produce blood cells. The present findings provide strong evidence for hemo-vasculogenesis, the simultaneous, local generation of blood and vessels likely derived from related precursor cell(s). The results do not invalidate the possibility that cells originating from distant sites (i.e. AGM region) could coexist in situ or in the circulation with blood cells that developed locally simultaneously with vessel morphogenesis. However, it should be noted that in many organs we observed erythroblasts before vascularization to that organ has occurred implying that distant cells could not access the tissue via the circulation. It is still possible that seeding from distant sites may occur through other mechanisms such as cell migration. Future work will be needed to ascertain this possibility.
The fact that hemo-vasculogenesis is widespread throughout the whole embryo during development may explain why extramedullary hematopoiesis occurs in adult life in almost any tissue and organ (ie. skull (21), brain (12), liver, spleen, kidneys, adrenal glands, breast, paravertebral and presacral areas (41), skin, testicles (33), heart (17), lung (46), gastrointestinal tract (39), pancreas (8), prostate (19) , and others) when blood availability is affected. It would appear that hematopoiesis can be reactivated as a compensatory mechanism in organs or regions where it previously occurred during embryonic and fetal life.
The above observations suggest that many adult tissues have the capacity to reactivate gene expression after a period of latency under circumstances of abnormal physiology or disease.
This process can occur in vivo under pathophysiological circumstances as a way of compensating the lack or malfunction of a specific tissue. As discussed above, the ability of adult tissues to generate blood could be explained either by the reactivation of a gene program in differentiated cells that have retained the capacity to reacquire an embryonic phenotype, or likely, the differentiation of resident precursor cells with hemo-vasculogenic potential when the physiological conditions demand it to maintain homeostasis. Examples for both possibilities seem to occur in nature for other systems (15; 23; 31) . Further work will be necessary to define which one of these possibilities occurs during extramedullary hematopoiesis.
A fundamental problem in experimental organogenesis is to obtain appropriate tissue circulation. A substantial amount of experimental work will be needed to understand the mechanisms underlying hemo-vasculogenesis. Nevertheless, because hemo-vasculogenesis can be reproduced in vitro and in transplanted embryonic tissues it offers new opportunities in tissue regeneration and organogenesis. Hb, hemoglobin; -SMA, alpha-smooth muscle actin; EM, electron microscopy. * mRNA and LacZ-transgene expression.
TABLES
